Articles producció científica> Medicina i Cirurgia

New Oral Anticoagulants vs Vitamin K Antagonists: Benefits for Health-Related Quality of Life in Patients with Atrial Fibrillation

  • Datos identificativos

    Identificador: imarina:6185073
    Autores:
    Alegret, JMViñolas, XArias, MAMartínez-Rubio, ARebollo, PRàfols, CMartínez-Sande, JL
    Resumen:
    New oral anticoagulants (NOAC) have demonstrated their efficacy as an alternative to vitamin K antagonists (VKA) in the prophylaxis of cardioembolic events in patients with atrial fibrillation (AF). However, evidence on the benefits of NOAC in health-related quality of life (HRQoL) is lacking. We evaluated changes in HRQoL related to oral anticoagulation therapy employing a specific questionnaire in a cohort of 416 patients with AF undergoing electrical cardioversion. In terms of HRQoL, we observed a progressive adaptation to treatment with VKA; satisfaction with NOAC remained constant. Older age, higher left ventricular ejection fraction and NOAC were associated with better HRQoL.
  • Otros:

    Autor según el artículo: Alegret, JM; Viñolas, X; Arias, MA; Martínez-Rubio, A; Rebollo, P; Ràfols, C; Martínez-Sande, JL
    Departamento: Medicina i Cirurgia
    Autor/es de la URV: Alegret Colomé, Josep Maria
    Palabras clave: Warfarin Vitamin k antagonists Self-management Ribaroxaban Prevention New oral anticoagulants Impact Health-related quality of life Events Elderly-patients Dabigatran Aspirin Ablation ribaroxaban. new oral anticoagulants health-related quality of life dabigatran
    Resumen: New oral anticoagulants (NOAC) have demonstrated their efficacy as an alternative to vitamin K antagonists (VKA) in the prophylaxis of cardioembolic events in patients with atrial fibrillation (AF). However, evidence on the benefits of NOAC in health-related quality of life (HRQoL) is lacking. We evaluated changes in HRQoL related to oral anticoagulation therapy employing a specific questionnaire in a cohort of 416 patients with AF undergoing electrical cardioversion. In terms of HRQoL, we observed a progressive adaptation to treatment with VKA; satisfaction with NOAC remained constant. Older age, higher left ventricular ejection fraction and NOAC were associated with better HRQoL.
    Áreas temáticas: Odontología Medicine, general & internal Medicine (miscellaneous) Medicine (all) Medicina veterinaria Medicina ii Medicina i Materiais General medicine Farmacia Ensino Ciências biológicas ii Ciências biológicas i
    Acceso a la licencia de uso: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 14491907
    Direcció de correo del autor: josepmaria.alegret@urv.cat
    Identificador del autor: 0000-0002-6117-5512
    Fecha de alta del registro: 2024-09-07
    Versión del articulo depositado: info:eu-repo/semantics/publishedVersion
    URL Documento de licencia: https://repositori.urv.cat/ca/proteccio-de-dades/
    Referencia al articulo segun fuente origial: International Journal Of Medical Sciences. 11 (7): 680-684
    Referencia de l'ítem segons les normes APA: Alegret, JM; Viñolas, X; Arias, MA; Martínez-Rubio, A; Rebollo, P; Ràfols, C; Martínez-Sande, JL (2014). New Oral Anticoagulants vs Vitamin K Antagonists: Benefits for Health-Related Quality of Life in Patients with Atrial Fibrillation. International Journal Of Medical Sciences, 11(7), 680-684. DOI: 10.7150/ijms.8916
    Entidad: Universitat Rovira i Virgili
    Año de publicación de la revista: 2014
    Tipo de publicación: Journal Publications
  • Palabras clave:

    Medicine (Miscellaneous),Medicine, General & Internal
    Warfarin
    Vitamin k antagonists
    Self-management
    Ribaroxaban
    Prevention
    New oral anticoagulants
    Impact
    Health-related quality of life
    Events
    Elderly-patients
    Dabigatran
    Aspirin
    Ablation
    ribaroxaban.
    new oral anticoagulants
    health-related quality of life
    dabigatran
    Odontología
    Medicine, general & internal
    Medicine (miscellaneous)
    Medicine (all)
    Medicina veterinaria
    Medicina ii
    Medicina i
    Materiais
    General medicine
    Farmacia
    Ensino
    Ciências biológicas ii
    Ciências biológicas i
  • Documentos:

  • Cerca a google

    Search to google scholar